Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06439381 |
| Consolidated Lead Sponsor | Chia Tai Tianqing Pharmaceutical Group Co |
| Therapeutic Condition Cohort | Respiratory and Pulmonary |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 119 participants (ACTUAL) |
| Registered Start Date | 2024-07-16 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Tongren Hospital, Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Guangxi Medical University Cancer Hospital | Nanning, China | Open Hospital Dossier -> |
| Henan Provincial People's Hospital | Zhengzhou, China | Open Hospital Dossier -> |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.